Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Mice were dosed via intraperitoneal injection at 10 ml/kg
Presented for research literature review only Brard E et al
As most of the available evidence stems from in vitro and preclinical studies, there remains a need for long-term and in vivo research to substantiate these findings and assess their translational relevance
Why do some dosing charts show doses above 15 mg
J Endocrinol (1993) 138(1):15966
In 2023, Eli Lilly synthesized injectable retatrutide, the first triple-action agonist targeting GLP-1, GIP, and glucagon receptors, which is currently undergoing Phase 3 clinical trials
US$ 28.24
US$ 20.24
US$ 21.17
US$ 20.43
US$ 24.18
US$ 28.83
US$ 28.57
